NCT04128475View on ClinicalTrials.gov

Observational Study of Cardiovascular Disease.

TerminatedOBSERVATIONAL
Enrollment

1,137

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Cardiovascular DiseasesCardiovascular MorbidityCoronary Heart DiseaseLow-density-lipoprotein-type
Interventions
OTHER

N/A - observational study.

N/A - observational study.

Trial Locations (3)

02115

TIMI Study Group, Boston

0424

Oslo University Hospital, Nydalen

Unknown

Imperial College London, London

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

The TIMI Study Group

OTHER

collaborator

Imperial College London

OTHER

collaborator

University of Oslo

OTHER

collaborator

Amgen

INDUSTRY

lead

University of Sydney

OTHER